Date	Name	Title	Type	Shares Traded	Price Range
Jun 28, 2007	topper james n	Director	Buy	4,734	11.32 - 11.47
Mar 10, 2008	fhm iv lp	Beneficial Owner (10% or more)	Buy	4,740	10.19 - 10.50
Mar 10, 2008	topper james n	Director	Buy	4,740	10.19 - 10.50
Jul 14, 2009	crowley john f	Officer	Automatic Sell	4,748	10.28
May 2, 2008	crowley john f	Officer	Automatic Sell	4,795	10.26 - 10.72
Aug 6, 2008	bloch stephen m	Director	Automatic Sell	4,879	15.60 - 16.77
Jun 16, 2008	patterson matthew r	Officer	Automatic Sell	4,900	11.12 - 11.25
Jan 8, 2009	palling david	Officer	Option Execute	4,924	0.64
Nov 23, 2010	crowley john f	Officer	Disposition (Non Open Market)	5,000	n/a
Jun 4, 2008	crowley john f	Officer	Automatic Sell	5,000	10.29 - 10.50
Dec 14, 2007	crowley john f	Officer	Option Execute	5,000	0.64
May 1, 2008	crowley john f	Officer	Automatic Sell	5,205	10.34 - 10.88
Feb 21, 2008	fhm iv lp	Beneficial Owner (10% or more)	Buy	5,500	9.86 - 10.50
Apr 14, 2008	patterson matthew r	Officer	Automatic Sell	5,500	10.00 - 10.73
Feb 21, 2008	topper james n	Director	Buy	5,500	9.86 - 10.50
Mar 4, 2008	crowley john f	Officer	Automatic Sell	5,503	10.00
Jul 15, 2008	bloch stephen m	Director	Automatic Sell	5,600	12.90
Feb 1, 2008	fhm iv lp	Beneficial Owner (10% or more)	Buy	5,600	9.01 - 9.08
Feb 1, 2008	topper james n	Director	Buy	5,600	9.01 - 9.08
Jul 24, 2008	bloch stephen m	Director	Automatic Sell	5,661	15.24
Showing 201-220 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.